chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my first vaccine dose on Friday July 2nd.  I had a sore arm where it was injection and headache like they told me I would.  Saturday July 3rd when I was on my way to work, my lower legs both felt very sore, very similar to how my arm felt.   Sunday July 4th, I took my 2 year old twins for a walk at the lake.  On our way back to the car,  I suddenly started walking funny and it felt like I was dragging my right foot.  When I got to the car, I went to rub my foot and noticed my entire right foot was numb along with half of my lower right leg.  The feeling was similar to what happens when your foot or leg falls asleep.    Come Tueaday July 6th my foot and leg were still numb.  I work full time and I'm constantly on my feet and it was getting hard and uncomfortable to walk.   After work I called my doctors office and they told me to call emergency services since the numbness came on suddenly.  I didn't call emergency services but did go to the ER where they ran a bunch of tests.
Right arm itching and area of erythema 1" width and 3" length and slightly warm to touch.
positive UPT on 9/20/21 LMP July 2021 patient experienced vaginal bleeding consistent with miscarriage on 10/13/21-10/18/21
She went to her doctor's office first this morning. Observed her left arm and there was brusing the size of a nickel at the injection site. Two inches below the injection site, there was redness and swelling that was 2 x 3 inches.
Suspected vaccination failure/In 2017 got the Shingrix vaccine, in 2021 and 2022 got shingles; Got Shingles for the 2nd and 3rd times; This case was reported by a consumer and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Pfizer Covid vaccine  with an associated reaction of herpes zoster (as a side effect of 2nd Pfizer Covid vaccine, the patient developed shingles).   On an unknown date, the patient received Shingrix. On an unknown date, more than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR152123   Additional Information: GSK receipt date: 20-Oct-2022 Reporter's comment: The six month later the shingles, the patient got the Shingrix vaccine in 2017 and during 2021 and again in 2022 (about 8 months later), the patient got shingles for the 2nd and 3rd times. The patient was prescribed Valacyclovir which worked, until the shingles showed up again. The patient asked that did they want to test the patient's blood to find out why the vaccine did not work on him/her. The case was linked with case US2022AMR152123, reported by same reporter for different product. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting.; Sender's Comments:  US-GSK-US2022AMR152123:Same Reporter/patient
headache, vertigo and severe nausea, sweating 16 minutes after vaccination given  left shoulder pain onset 90 minutes after vaccination given
Patient had previously received these vaccines at well visit in 2016. Due to error in abstracting paper chart to EMR, repeat doses of TDAP and MENACTRA were ordered and administered in error. Parent notified by MD of vaccination error, Mother denies any adverse effects or reaction to vaccinations.
Headache, Myalgia, NauseaVomiting, right arm was sore Narrative:  Other Relevant History:
This spontaneous report as received from a consumer (patient mother) refers to a male patient of unknown age. On an unknown date at 12 months of age, the patient was vaccinated with VARIVAX (Merck) 1350 U (dose, route and frequency were not reported). Other suspect therapies included M-M-R II (dose, route and frequency were not reported). On an unknown date at 24 months of age, the patient experienced autism. The consumer also stated that the patient also received other vaccines (brand names and manufactures unknown) on an unknown date. The consumer also reported that on an unknown date, inadvertently received 2 doses of polio vaccine (brand name and manufacturer unknown). The consumer called and stated that what was the duration of immunity after one dose of VARIVAX (Merck) and M-M-R II and also stated that can titers be drawn as evidence of immunity for VARIVAX (Merck) and M-M-R II. AE filed. No PQC. Preemie 7 weeks early titers. The outcome of the event autism was unknown. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 at 17:30 as dose 4 (booster), single (Lot number: gj2524) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Smoldering myeloma" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing). Concomitant medication(s) included: TAMIFLU, start date: 09Dec2022, stop date: 13Dec2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (13Dec2022) Positive, notes: Tested positive for Covid on 13Dec2022. Therapeutic measures were taken as a result of drug ineffective, covid-19 included PAXLOVID from 13Dec2022 to 17Dec2022.
Mother brought child to the ED with complaints that son has had 2 episodes of projectile vomiting this morning after each feeding. Also states that baby is more fussy than normal. No fever noted by mom or in ED. This started today prior to coming into the ED. Upon assessment baby was awake and alert, mom denies any difficulty breathing or sleeping. Thighs show no signs of redness. No rash noted on body.
I'm feeling like I have motion sickness.; This is a spontaneous report from a contactable other healthcare professional.   A 61-year-old male patient received bnt162b2, lot El0143, via an unspecified route of administration in the right arm on 06Jan2021 14:00 at single dose for covid-19 immunisation. The patient's medical has no relevant medical history. Patient has allergies to medications, food, or other products. The patient's concomitant medications were not reported. On an 07Jan2021 05:00, the patient felt like he has a motion sickness. The outcome of the event was recovering. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine.
Shingrix expired on 10/08/2023 and was administered on 10/10/2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 2459T, expiry date 08-OCT-2023) for prophylaxis.   On 10-OCT-2023, the patient received Shingrix. On 10-OCT-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Shingrix expired on 10/08/2023 and was administered on 10/10/2023).  The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 10-OCT-2023 The health care professional (HCP) reported that a Shingrix expired on 08th October 2023 and was administered on 10th October 2023, which led to expired vaccine used. The reporter consented to follow up via email
Severe reaction after receiving the second doze.  First doze was on April 12, 2021 Severe pain in joints especially in the hip and elbow areas.  Have been experience the pain till this day.   General weakness Body aches which lasted about 4-5 days.
Started crying 4 hours after the vaccines given at home with mom. Temp at 5 pm (in the office) 101.2 (R). (R) thigh red and swollen, examined by doctor in the office. Exam otherwise normal. Diagnosis: shot reaction.
Pain in back of neck; Pain in shoulders; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Patient received second dose of Pfizer vaccine on 2/5. Patient was anxious during administration of vaccine. Discussed how patient felt after first dose vaccine and SE experienced (sore arm only - tolerated well). After she calmed down, then administered vaccine when pt felt ready. ~10/15 min later patient reported flushing, trouble catching breath, pulsing headache & shaky. Gave 2 Benadryl, monitored BP/HR (normal), injection site (normal), no angioedema/blocking of oral cavity/throat. Patient advised to lay down and reported feeling better ~ 1 hour later.
This spontaneous report as received from a physician refers to 4 unspecified patients of unknown age and gender. No information about medical history, concurrent conditions and concomitant medication was reported. The physician reported that four unspecified patients, who had previously received doses of GARDASIL (dose, route, lot # and expiry date were not specified) on an unspecified dates, experienced severe pain at the injection site after receiving GARDASIL 9 intramuscularly (dose, lot # and expiry date were not provided), on an unspecified dates. It was stated that duration of injection site pain and discomfort lasted ten days to two weeks, after receiving GARDASIL 9. The patients had no other symptoms and on examination, they had normal strength and perfusion, with tenderness over the injection site. The patient s were treated with rest, cool compress, ibuprofen and they were instructed to follow-up, if the experienced any swelling and inflammation. The outcome of the events and causality assessment were not provided. Additional information has been requested.
Patient became anxious and had shortness of breath.  Vital signs were with in normal limits and after 15 min time of observation patient was calm and went home.
I recieved the booster moderna vaccine on 11/18/21.  On 11/19/21 I felt tired all day nothing major.  Then around 4pm my whole body started shaking, my chest hurt, I was cold and then hot, I was breathing really fast as well.  I called 911 and they came and I went to the ER.  At the ER they ran a bunch of tests and determined it was myocarditis caused by the Moderna vaccine.  I was then admitted to the hospital for observation overnight.  The next day 11/20/21 I got a ultrasound of my heart and it was determined that it was normal and that I could go home.
Achy; Fever; Chillls; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), PYREXIA (Fever) and CHILLS (Chillls) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure inadequately controlled. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), BIOTIN, VITAMIN B3, VITAMIN B12 NOS and Blood Pressure Medicine for an unknown indication.    On 24-Feb-2021 at 2:20 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021 at 8:00 PM, the patient experienced PAIN (Achy), PYREXIA (Fever) and CHILLS (Chillls). On 25-Feb-2021 at 4:00 AM, PAIN (Achy), PYREXIA (Fever) and CHILLS (Chillls) had resolved.            No treatment information was provided.
severe rash head to waist; major migraines; severe swelling in arm, legs and face; severe swelling in arm, legs and face; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration, administered in left arm on 12May2021 09:30 (at the age of 44-year-old) as 2nd dose, single for COVID-19 immunisation. Medical history included allergies to tree nuts, shellfish, and lots of medications, fibromyalgia, small fibre neuropathy, brain lesions, asthma, thrombocytopenia, chronic arthritis, nerve damage in elbows and hands, and complex regional pain syndrome (CRPS). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medication included lisdexamfetamine mesilate (VYVANSE). The patient previously took the first dose of bnt162b2 on 21Apr2021 10:30 (at the age of 44 years old) in the right arm for COVID-19 immunization and experienced extremely sick, affected neurological, and increased pain in fibro with right arm still not fully better left arm same issues neurological wise. On 12May2021, the patient experienced severe rash head to waist, major migraines, and severe swelling in arm, legs and face. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with prednisone, diphenhydramine (BENADRYL), and epinephrine (epi). Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
53 y/o woman presented for her first COVID vaccine. She had hx of allergic reaction to IV Contrast in 2006 and 2014 - within minutes of receiving IV contrast for an imaging study she developed throat closing, difficulty breathing and vomiting. She has tolerated vaccinations and IV medications in the past without any problem. She also tolerated bowel prep for her colonoscopy a few years ago. Denies known allergy to PEG. I sent secure chat to her PCP and received approval to proceed with vaccination today.  The patient was warned of the increased risk of allergic reaction to the COVID vaccine due to her allergic reaction to IV Contrast in the past. She expressed understanding and stated she still wanted to receive the vaccine despite the increased risk.   10 min after receiving the vaccine she developed significant nausea and dry heaving. Vitals were within normal limits. Physical exam was unremarkable except for anxiety and vomiting.  18 min after the vaccine she developed lightheadedness and a headache. 27 min after the vaccine she developed diaphoresis and a sore throat. Vitals and physical exam were monitored closely.  30 min after the vaccine she developed itching of her ears, nose and posterior pharynx. She also c/o burning sensation from her nasal passage to her throat. She had coughing and throat clearing. Vitals were unremarkable. Exam revealed increased distress.  35 min after the vaccine she suddenly developed tightness of her throat associated with worsening throat itching and difficulty breathing.  Vitals: HR 110, Spo2 94%, BP 136/80, RR 20 PE: A&Ox4, appears anxious and is in acute distress, she had hands around her throat.  Cardio: tachycardic rate, regular rhythm, radial pulse 2+ Pulm: Tachypnea noted, lungs clear to auscultation, no wheezing, cap refill < 2 sec Skin: facial flushing noted, diaphoresis resolved, no urticaria, no swelling or erythema at injection site.  Expressed to patient that I was concerned about an allergic reaction occurring and described my next steps of administering EPI and calling EMS. She was agreeable.  EMS was called by CMA. Epi Autoinjector 0.3 mg injected into RIGHT upper outer thigh at 10:57 AM Her throat tightness, throat/ear/nasal itching, throat clearing, cough, lightheadedness and headache all resolved within 10 min after the EPI was given.  Oral benadryl 25 mg was given.   EMS arrived at 11:18 AM and took over care. The patient was agreeable to be transferred to ER for further monitoring.
Hospitalization for uti and colon problems. UTI failed outpatient treatment. ER disimpacted colon.
Pneumovax 9/12/02 L deltoid soreness later that day and increase erythema down arm, feverish, sweaty.
Patient began smelling smoke Felt that she was 'not completely hydrated' but yet was drinking a lot of water and did not feel dehydrated
Severe shortness of breath, pain in center of chest, center of chest right side of heart ached, heaviness and tightness in chest all the time, heart rate increase, heart palpitations, fatigue, swollen lymph nodes under both armpits, pain in armpits, headache, could not lie down on back or side as I could not breath, pain in left and right arms  more in left arm where shot given, rash off and on on left arm.
Patient stating 2-4 hours after receiving vaccine, constant dizziness began.  Was seen in office 3 days later, 2/8/21, at which time it continued.  Has a headache as well, but a chronic problem for him, not new with dizziness. Had not been able to work and dizziness worsened as the day went on. No ear pain or hearing changes. Initially had ringing in ears, but that had resolved by time of visit. Positive dix hallpike as well at visit.  Meclizine was prescribed. spoke with patient today, 2/11/21, and he states gradual improvement in vertigo.
suffered a full body allergic reaction to her lotion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 13Jan2022 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Unknown manufacturer , Unknown dose), for COVID-19 Immunization. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "suffered a full body allergic reaction to her lotion".  Additional information: Patient had a massage from therapist and suffered a full body allergic reaction to lotion. Two weeks ago patient had another massage with the same results. She has not changed her formula for her lotion and patient been going to her for over a year with no reaction. patient wondering if the booster somehow messed with my immune system causing the allergic reaction.  The lot number for bnt162b2 was not provided and will be requested during follow up.
15 second generalized seizure slightly more than 48 hours after vaccine given. No fever. No IH seizure. Witnessed by mother who is RN. Eval at UCC normal. Child normal since event. Born preemie at 30 weeks benign NB course.
4 month old with fever experienced vomiting and onset of red urticarial rash and gagging 3 days after administration of ROTATEQ.  Seen in ER, appeared well with recovering urticarial rash.
Extreme dizziness 5 min post injection  Extreme dizziness that lead to fainting 26 hours post injection.   Continues dizziness  Unable to perform normal daily functions
pt recv vax & approx 8.5 hr later pt vomited & was reported to be staring;10 hr post vax pt exp sz & was hosp;
has developed where she can never have children again after getting the vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFERTILITY (non-serious), outcome "unknown", described as "has developed where she can never have children again after getting the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I got a flu shot and the injection itself was very painful.  Since then, I have had significant pain in my left arm.  I had no mobility in my arm for about 3 days.  After two doctors visits, and 3 different kinds of pain killers, I now have movement back, however, I still have chronic pain.
light swelling like a bee sting apper on left wrist; itching/pruritus; rash "like a bee sting" of left wrist; This spontaneous case was reported by a patient and describes the occurrence of JOINT SWELLING (light swelling like a bee sting apper on left wrist), PRURITUS (itching/pruritus) and RASH (rash "like a bee sting" of left wrist) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 013A214) for COVID-19 vaccination.     Concomitant products included MELOXICAM from 02-Jan-2010 to an unknown date and VALSARTAN from 02-Jan-2010 to an unknown date for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash "like a bee sting" of left wrist). On an unknown date, the patient experienced JOINT SWELLING (light swelling like a bee sting apper on left wrist) and PRURITUS (itching/pruritus). At the time of the report, JOINT SWELLING (light swelling like a bee sting apper on left wrist), PRURITUS (itching/pruritus) and RASH (rash "like a bee sting" of left wrist) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant included pain killer was included. GBmetalic hcl for unknown indication on 02-Jan-2010.   No treatment information was provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Additional information received include no new significant information On 27-Jul-2021: Updated race, height, con med added.
Information has been received from a physician concerning a patient who was vaccinated with Varivax. "Some time ago" the patient experienced shingles. It was reported that the shingles lesions were located on the leg. Recovery status was unknown. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
I had a sebaceous cyst on my left ring finger it was a big bump but later that night it was gone
18-40 hours after getting vaccine: sensitivity to light headache with light activity (walking more than 5 minutes) fatigue  muscle/joint pain injection site swelling and redness soreness at injection site (lasting 48 hours +)